. 2026 Jan 1;23(1):283–292. doi: 10.7150/ijms.119821

Table 2.

Patients with Hepatocellular Carcinoma: Non-death and Death (n = 225,631)

Variable	Non-death (n = 65,497)		Death (n = 160,134)		p Value
Variable	n/means	%/±SD	n/means	%/±SD	p Value
Sex					<0.0001
Male	42,745	65.31	108,106	67.58
Female	22,702	34.69	51,872	32.42
Chemotherapy					0.0005
No	95	0.15	349	0.22
Yes	65,402	99.85	159,785	99.78
Targeted therapy					<0.0001
No	2,202	3.36	877	0.55
Yes	63,295	96.64	159,257	99.45
Immunotherapy					<0.0001
No	2247	3.43	951	0.59
Yes	63,250	96.57	159,183	99.41
TAE					<0.0001
No	56,803	86.73	155,790	97.29
Yes	8694	13.27	4344	2.71
TACE					<0.0001
No	56,804	86.73	155,752	97.26
Yes	8,693	13.27	4,382	2.74
Hepatectomy					<0.0001
No	37,415	57.12	135,223	84.44
Yes	28,082	42.88	24,911	15.56
TAE+Chemotherapy					<0.0001
No	56,803	86.73	155,790	97.29
Yes	8,694	13.27	4,344	2.71
TACE+Chemotherapy					<0.0001
No	56,804	86.73	155,752	97.26
Yes	8,693	13.27	4,382	2.74
Hepatectomy+Chemotherapy					<0.0001
No	37,415	57.12	135,223	84.44
Yes	28,082	42.88	24,911	15.56
TAE+ Targeted therapy					<0.0001
No	56,803	86.73	155,790	97.29
Yes	8,694	13.27	4,344	2.71
TACE+ Targeted therapy					<0.0001
No	56,807	86.73	155,752	97.26
Yes	8,690	13.27	4,382	2.74
Hepatectomy + Targeted therapy					<0.0001
No	37,415	57.12	135,223	84.44
Yes	28,082	42.88	24,911	15.56
TAE+ Immunotherapy					<0.0001
No	56,803	86.73	155,790	97.29
Yes	8,694	13.27	4,344	2.71
TACE+ Immunotherapy					<0.0001
No	56,807	86.73	155,752	97.26
Yes	8,690	13.27	4,382	2.74
Hepatectomy + Immunotherapy					<0.0001
No	37,415	57.12	135,223	84.44
Yes	28,082	42.88	24,911	15.56
TAE + Chemotherapy + Targeted therapy					<0.0001
No	56,803	86.73	155,790	97.29
Yes	8,694	13.27	4,344	2.71
TACE + Chemotherapy + Targeted therapy					<0.0001
No	56,807	86.73	155,752	97.26
Yes	8,690	13.27	4,382	2.74
Hepatectomy + Chemotherapy+ Targeted therapy					<0.0001
No	37,415	57.12	135,223	84.44
Yes	28,082	42.88	24,911	15.56
TAE + Chemotherapy + Immunotherapy					<0.0001
No	56,803	86.73	155,790	97.29
Yes	8,694	13.27	4,344	2.71
TACE + Chemotherapy + Immunotherapy					<0.0001
No	56,807	86.73	155,752	97.26
Yes	8,690	13.27	4,382	2.74
Hepatectomy + Chemotherapy + Immunotherapy					<0.0001
No	37,415	57.12	135,223	84.44
Yes	28,082	42.88	24,911	15.56
TAE+ Targeted therapy + Immunotherapy					<0.0001
No	56,803	86.73	155,790	97.29
Yes	8,694	13.27	4,344	2.71
TACE+ Targeted therapy + Immunotherapy					<0.0001
No	56,807	86.73	155,752	97.26
Yes	8,690	13.27	4,382	2.74
Hepatectomy + Targeted therapy + Immunotherapy					<0.0001
No	37,415	57.12	135,223	84.44
Yes	28,082	42.88	24,911	15.56
TAE + Chemotherapy+ Targeted therapy + Immunotherapy					<0.0001
No	56,803	86.73	155,790	97.29
Yes	8,694	13.27	4,344	2.71
TACE + Chemotherapy + Targeted therapy + Immunotherapy					<0.0001
No	56,807	86.73	155,752	97.26
Yes	8,690	13.27	4,382	2.74
Hepatectomy + Chemotherapy + Targeted therapy + Immunotherapy					<0.0001
No	37,415	57.12	135,223	84.44
Yes	28,082	42.88	24,911	15.56